Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "DeepBlue® COVID-19 (SARS-CoV-2) Antibody Test Kit"
The FDA Advisory No. 1037-20 warns healthcare professionals and the public against the purchase and use of the uncertified "DeepBlue COVID-19 (SARS-CoV-2) Antibody Test Kit." Following a surveillance check, the FDA confirmed that this test kit lacks the necessary certification and special authorization, violating Republic Act No. 9711, which prohibits the sale and distribution of unapproved health products. The agency emphasizes that the unregistered kit has not undergone the required evaluation, thus raising concerns about its safety and efficacy. Additionally, FDA Circular 2020-016 restricts the online sale of certified COVID-19 antibody test kits. The advisory encourages reporting any unregistered medical devices through the FDA's online platform.
Law Information
- Reference Number
- FDA Advisory No. 1037-20
- Date Enacted
- Subcategory
- Food and Drugs Administration of the Philippines
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
June 4, 2020
FDA ADVISORY NO. 1037-20
| TO | : | All Healthcare Professionals and the General Public |
| SUBJECT | : | Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "DeepBlue® COVID-19 (SARS-CoV-2) Antibody Test Kit" |
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public against the sale and purchase of the uncertified COVID-19 test kit:
Figure 1. Uncertified DeepBlue® COVID-19 (SARS-CoV-2) Antibody Test Kit
The FDA verified through post-marketing surveillance conducted on 14 May 2020 that the abovementioned medical device is not certified and/or no Special Certification has been issued. Pursuant to the Republic Act No. 9711, otherwise known as the "Food and Drug Administration Act of 2009," the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising or sponsorship of health products without the proper authorization is prohibited. CAIHTE
Since this unregistered medical device has not gone through evaluation process of the FDA, the agency cannot assure its quality and safety.
Furthermore, FDA Circular 2020-016 entitled "Prohibition of Online Selling of FDA Certified COVID-19 Antibody Test Kits" prohibits online selling and commercial use of such products.
For more information and inquiries, kindly contact the FDA Center for Device Regulation, Radiation Health and Research through e-mail at [email protected].
To report any sale or distribution of unregistered/uncertified medical device, the online reporting facility, eReport can be accessed at www.fda.gov.ph/ereport.
Dissemination of this advisory to all concerned is hereby requested.
(SGD.) ROLANDO ENRIQUE D. DOMINGO, MD
Director General
Cite This Law
Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "DeepBlue® COVID-19 (SARS-CoV-2) Antibody Test Kit", FDA Advisory No. 1037-20, Jun 4, 2020 (Philippines)
Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "DeepBlue® COVID-19 (SARS-CoV-2) Antibody Test Kit", FDA Advisory No. 1037-20 (Phil. 2020)
Related Laws
- Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "Testsealabs® One Step Rapid Test-SARS-cov-2 IgG/IgM Test Cassette"FDA Advisory No. 1054-20 • Jun 10, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Health Warning against the Purchase and Use of the Uncertified COVID-19 Test Kit "Wiz Biotech Diagnostic Kit (Colloidal Gold) for IgG/IgM Antibody to SARS-CoV-2"FDA Advisory No. 1080-20 • Jun 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Health Warning against the Purchase and Use of Disinfectants/Biocides Products with Misleading Health Claims That Decrease the Risk for Corona Virus Disease (COVID-19) InfectionFDA Advisory No. 852-20 • May 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Varying Specifications and Use of COVID-19 Rapid Antibody Test KitsFDA Advisory No. 671-20 • Apr 18, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Guidance on Use of COVID-19 Rapid Antibody-based Test KitsDOH Department Circular No. 2020-0160 • Mar 31, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- List of Approved COVID-19 Test Kits for Commercial UseFDA Advisory No. 409-20 • Mar 19, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law